127 related articles for article (PubMed ID: 15633605)
1. Pharmaceutical reversal of insulin resistance.
Lautt WW; Macedo MP; Sadri P; Legare DJ; Reid MA; Guarino MP
Proc West Pharmacol Soc; 2004; 47():30-2. PubMed ID: 15633605
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholinesterase antagonist potentiated insulin action in fed but not fasted state.
Schafer J; Legare DJ; Lautt WW
J Pharmacol Exp Ther; 2010 May; 333(2):621-8. PubMed ID: 20133391
[TBL] [Abstract][Full Text] [Related]
3. A proposed new paradigm for insulin resistance.
Lautt WW
Metab Syndr Relat Disord; 2003 Dec; 1(4):261-70. PubMed ID: 18370650
[TBL] [Abstract][Full Text] [Related]
4. Practice and principles of pharmacodynamic determination of HISS-dependent and HISS-independent insulin action: methods to quantitate mechanisms of insulin resistance.
Lautt WW
Med Res Rev; 2003 Jan; 23(1):1-14. PubMed ID: 12424750
[TBL] [Abstract][Full Text] [Related]
5. The HISS story overview: a novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes.
Lautt WW
Can J Physiol Pharmacol; 1999 Aug; 77(8):553-62. PubMed ID: 10543718
[TBL] [Abstract][Full Text] [Related]
6. Bethanechol and N-acetylcysteine mimic feeding signals and reverse insulin resistance in fasted and sucrose-induced diabetic rats.
Lautt WW; Schafer J; Macedo MP; Legare DJ
Can J Physiol Pharmacol; 2011 Feb; 89(2):135-42. PubMed ID: 21326345
[TBL] [Abstract][Full Text] [Related]
7. Hepatic parasympathetic role in insulin resistance on an animal model of hypertension.
Ribeiro RT; Afonso RA; Macedo MP
Metabolism; 2007 Feb; 56(2):227-33. PubMed ID: 17224337
[TBL] [Abstract][Full Text] [Related]
8. Glucose disposal by insulin, but not IGF-1, is dependent on the hepatic parasympathetic nerves.
Sadri P; Lautt WW
Can J Physiol Pharmacol; 2000 Oct; 78(10):807-12. PubMed ID: 11077981
[TBL] [Abstract][Full Text] [Related]
9. Insulin sensitivity in skeletal muscle regulated by a hepatic hormone, HISS.
Lautt WW
Can J Appl Physiol; 2005 Jun; 30(3):304-12. PubMed ID: 16129895
[TBL] [Abstract][Full Text] [Related]
10. A new paradigm for diabetes and obesity: the hepatic insulin sensitizing substance (HISS) hypothesis.
Lautt WW
J Pharmacol Sci; 2004 May; 95(1):9-17. PubMed ID: 15153645
[TBL] [Abstract][Full Text] [Related]
11. Insulin sensitization by voluntary exercise in aging rats is mediated through hepatic insulin sensitizing substance (HISS).
Chowdhury KK; Legare DJ; Lautt WW
Exp Gerontol; 2011 Jan; 46(1):73-80. PubMed ID: 20955773
[TBL] [Abstract][Full Text] [Related]
12. Defective hepatic nitric oxide action results in HISS-dependent insulin resistance in spontaneously hypertensive rats.
Afonso RA; Ribeiro RT; Macedo MP
Proc West Pharmacol Soc; 2004; 47():103-4. PubMed ID: 15633625
[TBL] [Abstract][Full Text] [Related]
13. Increased incidence of hepatic insulin-sensitizing substance (HISS)-dependent insulin resistance in female rats prenatally exposed to ethanol.
Sadri P; Legare DJ; Takayama S; Lautt WW
Can J Physiol Pharmacol; 2005 Apr; 83(4):383-7. PubMed ID: 15877113
[TBL] [Abstract][Full Text] [Related]
14. HISS, not insulin, causes vasodilation in response to administered insulin.
Ming Z; Lautt WW
J Appl Physiol (1985); 2011 Jan; 110(1):60-8. PubMed ID: 20829499
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance in two animal models of obesity: A comparison of HISS-dependent and HISS-independent insulin action in high-fat diet-fed and Zucker rats.
Afonso RA; Lautt WW; Ribeiro RT; Legare DJ; Macedo MP
Proc West Pharmacol Soc; 2007; 50():110-4. PubMed ID: 18605245
[TBL] [Abstract][Full Text] [Related]
16. Lifestyle impact on meal-induced insulin sensitization in health and prediabetes: a focus on diet, antioxidants, and exercise interventions.
Chowdhury KK; Legare DJ; Lautt WW
Can J Physiol Pharmacol; 2013 Feb; 91(2):91-100. PubMed ID: 23458192
[TBL] [Abstract][Full Text] [Related]
17. Neurogenic insulin resistance in guinea-pigs with cisplatin-induced neuropathy.
Szilvássy J; Sziklai I; Sári R; Németh J; Peitl B; Porszasz R; Lonovics J; Szilvássy Z
Eur J Pharmacol; 2006 Feb; 531(1-3):217-25. PubMed ID: 16438961
[TBL] [Abstract][Full Text] [Related]
18. Hepatic insulin resistance in non-insulin-dependent diabetes mellitus and the effects of a sulfonylurea in potentiating insulin action.
Amatruda JM; Salhanick AI; Chang CL
Diabetes Care; 1984; 7 Suppl 1():47-53. PubMed ID: 6376029
[TBL] [Abstract][Full Text] [Related]
19. Exercise enhancement of hepatic insulin-sensitising substance-mediated glucose uptake in diet-induced prediabetic rats.
Chowdhury KK; Legare DJ; Lautt WW
Br J Nutr; 2013 Mar; 109(5):844-52. PubMed ID: 23021417
[TBL] [Abstract][Full Text] [Related]
20. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
